Exjade
RxNorm concept 614084, brand name (bn).
- RxCUI
- 614084
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/614084 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- deferasirox 125 MG Tablet for Oral Suspension [Exjade] (SBD, ingredient of)
- deferasirox 250 MG Tablet for Oral Suspension [Exjade] (SBD, ingredient of)
- deferasirox 500 MG Tablet for Oral Suspension [Exjade] (SBD, ingredient of)
- Exjade Oral Liquid Product (SBDG, ingredient of)
- Exjade Oral Product (SBDG, ingredient of)
- deferasirox 125 MG [Exjade] (SBDC, ingredient of)
- deferasirox Tablet for Oral Suspension [Exjade] (SBDF, ingredient of)
- deferasirox 250 MG [Exjade] (SBDC, ingredient of)
- deferasirox 500 MG [Exjade] (SBDC, ingredient of)
- deferasirox (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 614084 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/614084 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 614084. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.